Business Context and Reporting Period
Company: BioCardia, Inc. (BCDA)
Filing Type: Form 8-K (Current Report)
Date of Report: June 25, 2025
Reporting Period: Single event date (June 25, 2025)
This filing reports a specific corporate event regarding intellectual property rather than a standard financial reporting period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 8-K is limited to reporting a specific event and does not contain financial statements or performance metrics.
Material Changes
Intellectual Property Grant: On June 25, 2025, the United States Patent Office granted US Patent No. 12,311,127 to BioCardia, Inc.
Patent Title: "Radial and Trans-endocardial Delivery Catheter."
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) announcing the patent grant but does not include specific forward-looking guidance, financial outlook, or detailed risk factors within the text of this report.
Unusual Items: None reported beyond the standard patent grant event.
Investor Verification Checklist
- Verify the scope and commercial applicability of US Patent No. 12,311,127 ("Radial and Trans-endocardial Delivery Catheter").
- Review the full text of the press release attached as Exhibit 99.1 for additional strategic context.
- Confirm the status of the company's product pipeline related to radial and trans-endocardial delivery systems.
- Check recent 10-Q or 10-K filings for the most current financial position, as this 8-K contains no financial data.